Global (United States, European Union and China) Microarray Scanner
Global (United States, European Union and China) Microarray Scanner

Microarray Scanner Comprehensive Study by Type (Charge-Coupled Devices Microarray Scanners, Colorimetric Microarray Scanners, Fluorescence Microarray Scanners, Microarray Laser Scanners, Microarray Plate Scanners, Others), Application (Drug Discovery, Gene Expression, Mutation Detection, SNP analysis, Others), By End User (Academic Institutes, Diagnostic Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes) Players and Region - Global Market Outlook to 2026

Microarray Scanner Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Sep 2021 Edition 221 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Microarray Scanner Market Overview:
Microarray Scanners are systems used to gauge the fluorescent spaces of a DNA microarray to uncover data about the concurrent action of thousands of genes. Microarray scanners are broadly utilized in practical science, cellomics, quality articulation, and medication revelation research. Microarray Scanner, significant elements are sensitivity, goal, filter region, speed of the scan, and convenience. Microarray Scanners for the most part have red, green, and blue excitation frequencies and a wide decision of up to 8 emanation channels that empower imaging of a broad assortment of fluorophores (for example Cy3, Cy5, FITC, and Texas Red). Microarray Scanner framework with self-adjust that constantly acclimates to keep highlights while scanning, confocal optics that consider the sensitive location of low-abundance targets, or computerized multi fluorescence checking that permits multiplexing.

Growth Drivers
  • Increase in the population with infectious diseases such as COVID-19
  • Increasing focus in gene expression and drug discovery to address the different infection spread

Roadblocks
  • The high initial cost of the owning microarray scanner
  • Lack of skilled personnelís to operate and handle the concerned activity

Opportunities
  • Development of advanced technology which is prominent in delivering the required result
  • Increase in research activities and develop medical infrastructure in developing countries

Challenges
  • Stringent regulatory authorities of different countries


Competitive Landscape:
The Microarray Scanner Market is engaged with different small and giant organizations. Most of the organizations in the microarray scanners market are entering into strategic partnerships to increase the availability of high technology solutions about innovative microarray platforms. Moreover, these companies are involved in the expansion activities of their business operations in developing countries to avail a competitive advantage over other players.
Some of the key players profiled in the report are Agilent Technologies (United States), Berthold Technologies GmbH & Co. KG. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), GE Healthcare (General Electric Company) (United States), Illumina, Inc. (United States), Innopsys Inc. (United States), Molecular Devices, LLC. (Danaher Corporation) (United States), PerkinElmer, Inc. (United States), Thermo Fisher Scientific (United States) and Integrated Gulf Biosystems (Abu Dhabi). Additionally, following companies can also be profiled that are part of our coverage like Arrayit (United States), Bioautomation Corporation (United States), EUROIMMUN (Germany), Bio-Rad Laboratories, Inc. (United States) and Molecular Devices (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Microarray Scanner market by 2026. Considering Market by By End User, the sub-segment i.e. Academic Institutes will boost the Microarray Scanner market.

Latest Market Insights:
On 20 January 2021, Exact Therapeutics, a clinical-stage precision medicine company, announced a collaboration with GE Healthcare to develop an innovative ultrasound probe to be used in forthcoming studies. This collaboration with GE Healthcare, a leader in the field of diagnostic imaging and ultrasound, developing an innovative ultrasound probe to enable the effective deployment of the ACT therapeutic amplification platform.

The Food and Drug Administration (FDA), the regulatory authority of the United States encourages the development of new technologies regarding microarrays which may improve and streamline assessments of safety and the effectiveness of medical products for the benefit of public health.

What Can be Explored with the Microarray Scanner Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Microarray Scanner Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Microarray Scanner
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Microarray Scanner market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Microarray Scanner market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Industry Associations, Government Regulatory Authorities, Health and Medical Equipment Suppliers, Health and Medical Equipment Manufacturer, Bio-Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global Microarray Scanner Market?
The Microarray Scanner market is expected to see a CAGR of % during projected year 2020 to 2026.

2. Who are the top performing companies in Microarray Scanner Market?
Top performing companies in the Global Microarray Scanner market are Agilent Technologies (United States), Berthold Technologies GmbH & Co. KG. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), GE Healthcare (General Electric Company) (United States), Illumina, Inc. (United States), Innopsys Inc. (United States), Molecular Devices, LLC. (Danaher Corporation) (United States), PerkinElmer, Inc. (United States), Thermo Fisher Scientific (United States) and Integrated Gulf Biosystems (Abu Dhabi), to name a few.

3. What trending factors would impact Microarray Scanner Market growth most?
"Increase in drug discovery activities in health care " is seen as one of major influencing trends for Microarray Scanner Market during projected period 2020-2026.

Report Objectives / Segmentation Covered
By Type
  • Charge-Coupled Devices Microarray Scanners
  • Colorimetric Microarray Scanners
  • Fluorescence Microarray Scanners
  • Microarray Laser Scanners
  • Microarray Plate Scanners
  • Others
By Application
  • Drug Discovery
  • Gene Expression
  • Mutation Detection
  • SNP analysis
  • Others
By By End User
  • Academic Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the population with infectious diseases such as COVID-19
      • 3.2.2. Increasing focus in gene expression and drug discovery to address the different infection spread
    • 3.3. Market Challenges
      • 3.3.1. Stringent regulatory authorities of different countries
    • 3.4. Market Trends
      • 3.4.1. Increase in drug discovery activities in health care
      • 3.4.2. Growing research and development for technological advancements, and wide applications of microarray analysis
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Microarray Scanner, by Type, Application, By End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Microarray Scanner (Value)
      • 5.2.1. Global Microarray Scanner by: Type (Value)
        • 5.2.1.1. Charge-Coupled Devices Microarray Scanners
        • 5.2.1.2. Colorimetric Microarray Scanners
        • 5.2.1.3. Fluorescence Microarray Scanners
        • 5.2.1.4. Microarray Laser Scanners
        • 5.2.1.5. Microarray Plate Scanners
        • 5.2.1.6. Others
      • 5.2.2. Global Microarray Scanner by: Application (Value)
        • 5.2.2.1. Drug Discovery
        • 5.2.2.2. Gene Expression
        • 5.2.2.3. Mutation Detection
        • 5.2.2.4. SNP analysis
        • 5.2.2.5. Others
      • 5.2.3. Global Microarray Scanner by: By End User (Value)
        • 5.2.3.1. Academic Institutes
        • 5.2.3.2. Diagnostic Laboratories
        • 5.2.3.3. Hospitals
        • 5.2.3.4. Pharmaceutical & Biotechnology Companies
        • 5.2.3.5. Research Institutes
      • 5.2.4. Global Microarray Scanner Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Microarray Scanner (Price)
      • 5.3.1. Global Microarray Scanner by: Type (Price)
  • 6. Microarray Scanner: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Agilent Technologies (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Berthold Technologies GmbH & Co. KG. (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GE Healthcare (General Electric Company) (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Illumina, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Innopsys Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Molecular Devices, LLC. (Danaher Corporation) (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. PerkinElmer, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Integrated Gulf Biosystems (Abu Dhabi)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Microarray Scanner Sale, by Type, Application, By End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Microarray Scanner (Value)
      • 7.2.1. Global Microarray Scanner by: Type (Value)
        • 7.2.1.1. Charge-Coupled Devices Microarray Scanners
        • 7.2.1.2. Colorimetric Microarray Scanners
        • 7.2.1.3. Fluorescence Microarray Scanners
        • 7.2.1.4. Microarray Laser Scanners
        • 7.2.1.5. Microarray Plate Scanners
        • 7.2.1.6. Others
      • 7.2.2. Global Microarray Scanner by: Application (Value)
        • 7.2.2.1. Drug Discovery
        • 7.2.2.2. Gene Expression
        • 7.2.2.3. Mutation Detection
        • 7.2.2.4. SNP analysis
        • 7.2.2.5. Others
      • 7.2.3. Global Microarray Scanner by: By End User (Value)
        • 7.2.3.1. Academic Institutes
        • 7.2.3.2. Diagnostic Laboratories
        • 7.2.3.3. Hospitals
        • 7.2.3.4. Pharmaceutical & Biotechnology Companies
        • 7.2.3.5. Research Institutes
      • 7.2.4. Global Microarray Scanner Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Microarray Scanner (Price)
      • 7.3.1. Global Microarray Scanner by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Microarray Scanner: by Type(USD Million)
  • Table 2. Microarray Scanner Charge-Coupled Devices Microarray Scanners , by Region USD Million (2015-2020)
  • Table 3. Microarray Scanner Colorimetric Microarray Scanners , by Region USD Million (2015-2020)
  • Table 4. Microarray Scanner Fluorescence Microarray Scanners , by Region USD Million (2015-2020)
  • Table 5. Microarray Scanner Microarray Laser Scanners , by Region USD Million (2015-2020)
  • Table 6. Microarray Scanner Microarray Plate Scanners , by Region USD Million (2015-2020)
  • Table 7. Microarray Scanner Others , by Region USD Million (2015-2020)
  • Table 8. Microarray Scanner: by Application(USD Million)
  • Table 9. Microarray Scanner Drug Discovery , by Region USD Million (2015-2020)
  • Table 10. Microarray Scanner Gene Expression , by Region USD Million (2015-2020)
  • Table 11. Microarray Scanner Mutation Detection , by Region USD Million (2015-2020)
  • Table 12. Microarray Scanner SNP analysis , by Region USD Million (2015-2020)
  • Table 13. Microarray Scanner Others , by Region USD Million (2015-2020)
  • Table 14. Microarray Scanner: by By End User(USD Million)
  • Table 15. Microarray Scanner Academic Institutes , by Region USD Million (2015-2020)
  • Table 16. Microarray Scanner Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 17. Microarray Scanner Hospitals , by Region USD Million (2015-2020)
  • Table 18. Microarray Scanner Pharmaceutical & Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 19. Microarray Scanner Research Institutes , by Region USD Million (2015-2020)
  • Table 20. South America Microarray Scanner, by Country USD Million (2015-2020)
  • Table 21. South America Microarray Scanner, by Type USD Million (2015-2020)
  • Table 22. South America Microarray Scanner, by Application USD Million (2015-2020)
  • Table 23. South America Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 24. Brazil Microarray Scanner, by Type USD Million (2015-2020)
  • Table 25. Brazil Microarray Scanner, by Application USD Million (2015-2020)
  • Table 26. Brazil Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 27. Argentina Microarray Scanner, by Type USD Million (2015-2020)
  • Table 28. Argentina Microarray Scanner, by Application USD Million (2015-2020)
  • Table 29. Argentina Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 30. Rest of South America Microarray Scanner, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Microarray Scanner, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 33. Asia Pacific Microarray Scanner, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Microarray Scanner, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Microarray Scanner, by Application USD Million (2015-2020)
  • Table 36. Asia Pacific Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 37. China Microarray Scanner, by Type USD Million (2015-2020)
  • Table 38. China Microarray Scanner, by Application USD Million (2015-2020)
  • Table 39. China Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 40. Japan Microarray Scanner, by Type USD Million (2015-2020)
  • Table 41. Japan Microarray Scanner, by Application USD Million (2015-2020)
  • Table 42. Japan Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 43. India Microarray Scanner, by Type USD Million (2015-2020)
  • Table 44. India Microarray Scanner, by Application USD Million (2015-2020)
  • Table 45. India Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 46. South Korea Microarray Scanner, by Type USD Million (2015-2020)
  • Table 47. South Korea Microarray Scanner, by Application USD Million (2015-2020)
  • Table 48. South Korea Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 49. Taiwan Microarray Scanner, by Type USD Million (2015-2020)
  • Table 50. Taiwan Microarray Scanner, by Application USD Million (2015-2020)
  • Table 51. Taiwan Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 52. Australia Microarray Scanner, by Type USD Million (2015-2020)
  • Table 53. Australia Microarray Scanner, by Application USD Million (2015-2020)
  • Table 54. Australia Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Microarray Scanner, by Type USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific Microarray Scanner, by Application USD Million (2015-2020)
  • Table 57. Rest of Asia-Pacific Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 58. Europe Microarray Scanner, by Country USD Million (2015-2020)
  • Table 59. Europe Microarray Scanner, by Type USD Million (2015-2020)
  • Table 60. Europe Microarray Scanner, by Application USD Million (2015-2020)
  • Table 61. Europe Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 62. Germany Microarray Scanner, by Type USD Million (2015-2020)
  • Table 63. Germany Microarray Scanner, by Application USD Million (2015-2020)
  • Table 64. Germany Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 65. France Microarray Scanner, by Type USD Million (2015-2020)
  • Table 66. France Microarray Scanner, by Application USD Million (2015-2020)
  • Table 67. France Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 68. Italy Microarray Scanner, by Type USD Million (2015-2020)
  • Table 69. Italy Microarray Scanner, by Application USD Million (2015-2020)
  • Table 70. Italy Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 71. United Kingdom Microarray Scanner, by Type USD Million (2015-2020)
  • Table 72. United Kingdom Microarray Scanner, by Application USD Million (2015-2020)
  • Table 73. United Kingdom Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 74. Netherlands Microarray Scanner, by Type USD Million (2015-2020)
  • Table 75. Netherlands Microarray Scanner, by Application USD Million (2015-2020)
  • Table 76. Netherlands Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 77. Rest of Europe Microarray Scanner, by Type USD Million (2015-2020)
  • Table 78. Rest of Europe Microarray Scanner, by Application USD Million (2015-2020)
  • Table 79. Rest of Europe Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 80. MEA Microarray Scanner, by Country USD Million (2015-2020)
  • Table 81. MEA Microarray Scanner, by Type USD Million (2015-2020)
  • Table 82. MEA Microarray Scanner, by Application USD Million (2015-2020)
  • Table 83. MEA Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 84. Middle East Microarray Scanner, by Type USD Million (2015-2020)
  • Table 85. Middle East Microarray Scanner, by Application USD Million (2015-2020)
  • Table 86. Middle East Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 87. Africa Microarray Scanner, by Type USD Million (2015-2020)
  • Table 88. Africa Microarray Scanner, by Application USD Million (2015-2020)
  • Table 89. Africa Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 90. North America Microarray Scanner, by Country USD Million (2015-2020)
  • Table 91. North America Microarray Scanner, by Type USD Million (2015-2020)
  • Table 92. North America Microarray Scanner, by Application USD Million (2015-2020)
  • Table 93. North America Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 94. United States Microarray Scanner, by Type USD Million (2015-2020)
  • Table 95. United States Microarray Scanner, by Application USD Million (2015-2020)
  • Table 96. United States Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 97. Canada Microarray Scanner, by Type USD Million (2015-2020)
  • Table 98. Canada Microarray Scanner, by Application USD Million (2015-2020)
  • Table 99. Canada Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 100. Mexico Microarray Scanner, by Type USD Million (2015-2020)
  • Table 101. Mexico Microarray Scanner, by Application USD Million (2015-2020)
  • Table 102. Mexico Microarray Scanner, by By End User USD Million (2015-2020)
  • Table 103. Microarray Scanner: by Type(USD/Units)
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Microarray Scanner: by Type(USD Million)
  • Table 115. Microarray Scanner Charge-Coupled Devices Microarray Scanners , by Region USD Million (2021-2026)
  • Table 116. Microarray Scanner Colorimetric Microarray Scanners , by Region USD Million (2021-2026)
  • Table 117. Microarray Scanner Fluorescence Microarray Scanners , by Region USD Million (2021-2026)
  • Table 118. Microarray Scanner Microarray Laser Scanners , by Region USD Million (2021-2026)
  • Table 119. Microarray Scanner Microarray Plate Scanners , by Region USD Million (2021-2026)
  • Table 120. Microarray Scanner Others , by Region USD Million (2021-2026)
  • Table 121. Microarray Scanner: by Application(USD Million)
  • Table 122. Microarray Scanner Drug Discovery , by Region USD Million (2021-2026)
  • Table 123. Microarray Scanner Gene Expression , by Region USD Million (2021-2026)
  • Table 124. Microarray Scanner Mutation Detection , by Region USD Million (2021-2026)
  • Table 125. Microarray Scanner SNP analysis , by Region USD Million (2021-2026)
  • Table 126. Microarray Scanner Others , by Region USD Million (2021-2026)
  • Table 127. Microarray Scanner: by By End User(USD Million)
  • Table 128. Microarray Scanner Academic Institutes , by Region USD Million (2021-2026)
  • Table 129. Microarray Scanner Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 130. Microarray Scanner Hospitals , by Region USD Million (2021-2026)
  • Table 131. Microarray Scanner Pharmaceutical & Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 132. Microarray Scanner Research Institutes , by Region USD Million (2021-2026)
  • Table 133. South America Microarray Scanner, by Country USD Million (2021-2026)
  • Table 134. South America Microarray Scanner, by Type USD Million (2021-2026)
  • Table 135. South America Microarray Scanner, by Application USD Million (2021-2026)
  • Table 136. South America Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 137. Brazil Microarray Scanner, by Type USD Million (2021-2026)
  • Table 138. Brazil Microarray Scanner, by Application USD Million (2021-2026)
  • Table 139. Brazil Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 140. Argentina Microarray Scanner, by Type USD Million (2021-2026)
  • Table 141. Argentina Microarray Scanner, by Application USD Million (2021-2026)
  • Table 142. Argentina Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 143. Rest of South America Microarray Scanner, by Type USD Million (2021-2026)
  • Table 144. Rest of South America Microarray Scanner, by Application USD Million (2021-2026)
  • Table 145. Rest of South America Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 146. Asia Pacific Microarray Scanner, by Country USD Million (2021-2026)
  • Table 147. Asia Pacific Microarray Scanner, by Type USD Million (2021-2026)
  • Table 148. Asia Pacific Microarray Scanner, by Application USD Million (2021-2026)
  • Table 149. Asia Pacific Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 150. China Microarray Scanner, by Type USD Million (2021-2026)
  • Table 151. China Microarray Scanner, by Application USD Million (2021-2026)
  • Table 152. China Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 153. Japan Microarray Scanner, by Type USD Million (2021-2026)
  • Table 154. Japan Microarray Scanner, by Application USD Million (2021-2026)
  • Table 155. Japan Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 156. India Microarray Scanner, by Type USD Million (2021-2026)
  • Table 157. India Microarray Scanner, by Application USD Million (2021-2026)
  • Table 158. India Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 159. South Korea Microarray Scanner, by Type USD Million (2021-2026)
  • Table 160. South Korea Microarray Scanner, by Application USD Million (2021-2026)
  • Table 161. South Korea Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 162. Taiwan Microarray Scanner, by Type USD Million (2021-2026)
  • Table 163. Taiwan Microarray Scanner, by Application USD Million (2021-2026)
  • Table 164. Taiwan Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 165. Australia Microarray Scanner, by Type USD Million (2021-2026)
  • Table 166. Australia Microarray Scanner, by Application USD Million (2021-2026)
  • Table 167. Australia Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 168. Rest of Asia-Pacific Microarray Scanner, by Type USD Million (2021-2026)
  • Table 169. Rest of Asia-Pacific Microarray Scanner, by Application USD Million (2021-2026)
  • Table 170. Rest of Asia-Pacific Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 171. Europe Microarray Scanner, by Country USD Million (2021-2026)
  • Table 172. Europe Microarray Scanner, by Type USD Million (2021-2026)
  • Table 173. Europe Microarray Scanner, by Application USD Million (2021-2026)
  • Table 174. Europe Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 175. Germany Microarray Scanner, by Type USD Million (2021-2026)
  • Table 176. Germany Microarray Scanner, by Application USD Million (2021-2026)
  • Table 177. Germany Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 178. France Microarray Scanner, by Type USD Million (2021-2026)
  • Table 179. France Microarray Scanner, by Application USD Million (2021-2026)
  • Table 180. France Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 181. Italy Microarray Scanner, by Type USD Million (2021-2026)
  • Table 182. Italy Microarray Scanner, by Application USD Million (2021-2026)
  • Table 183. Italy Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 184. United Kingdom Microarray Scanner, by Type USD Million (2021-2026)
  • Table 185. United Kingdom Microarray Scanner, by Application USD Million (2021-2026)
  • Table 186. United Kingdom Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 187. Netherlands Microarray Scanner, by Type USD Million (2021-2026)
  • Table 188. Netherlands Microarray Scanner, by Application USD Million (2021-2026)
  • Table 189. Netherlands Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 190. Rest of Europe Microarray Scanner, by Type USD Million (2021-2026)
  • Table 191. Rest of Europe Microarray Scanner, by Application USD Million (2021-2026)
  • Table 192. Rest of Europe Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 193. MEA Microarray Scanner, by Country USD Million (2021-2026)
  • Table 194. MEA Microarray Scanner, by Type USD Million (2021-2026)
  • Table 195. MEA Microarray Scanner, by Application USD Million (2021-2026)
  • Table 196. MEA Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 197. Middle East Microarray Scanner, by Type USD Million (2021-2026)
  • Table 198. Middle East Microarray Scanner, by Application USD Million (2021-2026)
  • Table 199. Middle East Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 200. Africa Microarray Scanner, by Type USD Million (2021-2026)
  • Table 201. Africa Microarray Scanner, by Application USD Million (2021-2026)
  • Table 202. Africa Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 203. North America Microarray Scanner, by Country USD Million (2021-2026)
  • Table 204. North America Microarray Scanner, by Type USD Million (2021-2026)
  • Table 205. North America Microarray Scanner, by Application USD Million (2021-2026)
  • Table 206. North America Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 207. United States Microarray Scanner, by Type USD Million (2021-2026)
  • Table 208. United States Microarray Scanner, by Application USD Million (2021-2026)
  • Table 209. United States Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 210. Canada Microarray Scanner, by Type USD Million (2021-2026)
  • Table 211. Canada Microarray Scanner, by Application USD Million (2021-2026)
  • Table 212. Canada Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 213. Mexico Microarray Scanner, by Type USD Million (2021-2026)
  • Table 214. Mexico Microarray Scanner, by Application USD Million (2021-2026)
  • Table 215. Mexico Microarray Scanner, by By End User USD Million (2021-2026)
  • Table 216. Microarray Scanner: by Type(USD/Units)
  • Table 217. Research Programs/Design for This Report
  • Table 218. Key Data Information from Secondary Sources
  • Table 219. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Microarray Scanner: by Type USD Million (2015-2020)
  • Figure 5. Global Microarray Scanner: by Application USD Million (2015-2020)
  • Figure 6. Global Microarray Scanner: by By End User USD Million (2015-2020)
  • Figure 7. South America Microarray Scanner Share (%), by Country
  • Figure 8. Asia Pacific Microarray Scanner Share (%), by Country
  • Figure 9. Europe Microarray Scanner Share (%), by Country
  • Figure 10. MEA Microarray Scanner Share (%), by Country
  • Figure 11. North America Microarray Scanner Share (%), by Country
  • Figure 12. Global Microarray Scanner: by Type USD/Units (2015-2020)
  • Figure 13. Global Microarray Scanner share by Players 2020 (%)
  • Figure 14. Global Microarray Scanner share by Players (Top 3) 2020(%)
  • Figure 15. Global Microarray Scanner share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 18. Agilent Technologies (United States) Revenue: by Geography 2020
  • Figure 19. Berthold Technologies GmbH & Co. KG. (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Berthold Technologies GmbH & Co. KG. (Germany) Revenue: by Geography 2020
  • Figure 21. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 22. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 23. GE Healthcare (General Electric Company) (United States) Revenue, Net Income and Gross profit
  • Figure 24. GE Healthcare (General Electric Company) (United States) Revenue: by Geography 2020
  • Figure 25. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Illumina, Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Innopsys Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Innopsys Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Molecular Devices, LLC. (Danaher Corporation) (United States) Revenue, Net Income and Gross profit
  • Figure 30. Molecular Devices, LLC. (Danaher Corporation) (United States) Revenue: by Geography 2020
  • Figure 31. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. PerkinElmer, Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 34. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 35. Integrated Gulf Biosystems (Abu Dhabi) Revenue, Net Income and Gross profit
  • Figure 36. Integrated Gulf Biosystems (Abu Dhabi) Revenue: by Geography 2020
  • Figure 37. Global Microarray Scanner: by Type USD Million (2021-2026)
  • Figure 38. Global Microarray Scanner: by Application USD Million (2021-2026)
  • Figure 39. Global Microarray Scanner: by By End User USD Million (2021-2026)
  • Figure 40. South America Microarray Scanner Share (%), by Country
  • Figure 41. Asia Pacific Microarray Scanner Share (%), by Country
  • Figure 42. Europe Microarray Scanner Share (%), by Country
  • Figure 43. MEA Microarray Scanner Share (%), by Country
  • Figure 44. North America Microarray Scanner Share (%), by Country
  • Figure 45. Global Microarray Scanner: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Agilent Technologies (United States)
  • Berthold Technologies GmbH & Co. KG. (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • GE Healthcare (General Electric Company) (United States)
  • Illumina, Inc. (United States)
  • Innopsys Inc. (United States)
  • Molecular Devices, LLC. (Danaher Corporation) (United States)
  • PerkinElmer, Inc. (United States)
  • Thermo Fisher Scientific (United States)
  • Integrated Gulf Biosystems (Abu Dhabi)
Additional players considered in the study are as follows:
Arrayit (United States) , Bioautomation Corporation (United States) , EUROIMMUN (Germany) , Bio-Rad Laboratories, Inc. (United States) , Molecular Devices (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation